bell
The current prices are delayed by 15 mins, login to check live prices.
Remus Pharmaceuticals Ltd share price logo

Remus Pharmaceuticals Ltd Share Price

(REMUS)

₹2316▲0.29%

as on 04:03PM, 10 Jan 2025

Overview
News
Financials
Technicals

Remus Pharmaceuticals Ltd Performance

  • Day's Low

    Day's High

    ₹2,261.1
    Day's Price Range
    ₹2,348

  • 52 Week's Low

    52 Week's High

    ₹1,200
    52-Week Price Range
    ₹2,834.75
1 Month Return-7.79 %
3 Month Return-15 %
1 Year Return+ 36.54 %
Previous Close₹2,309.35
Open₹2,261.10
Volume1,600.00
Upper Circuit-
Lower Circuit-
Market Cap₹1,364.59Cr

Remus Pharmaceuticals Ltd Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹1,364.59 Cr
P/B Ratio12.38
EPS0
Dividend Yield0.06
SectorPharmaceuticals
ROE33.24

Remus Pharmaceuticals Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Remus Pharmaceuticals Ltd
Remus Pharmaceuticals Ltd
NA₹1,364.59 Cr83.12%0.51₹25 Cr₹212 Cr
Vivimed Labs Ltd
Vivimed Labs Ltd
NA₹0.00 Cr-12.06%0.77NANA
Astal Laboratories Ltd
Astal Laboratories Ltd
NA₹143.77 Cr157.37%0.51NANA
Denis Chem Lab Ltd
Denis Chem Lab Ltd
NA₹218.84 Cr68.1%0.51NANA
JFL Life Sciences Ltd
JFL Life Sciences Ltd
NA₹101.46 Cr7.74%0.57NANA
See all

About Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Limited, originally incorporated as Remus Pharmaceuticals Private Limited in 2015, is engaged in the marketing and distribution of finished formulations of pharmaceutical drugs. It deals in various drug forms such as capsules, creams, gel, injection, tablets, etc. and supplies therapeutic drugs like ACE inhibitors, anaesthetics, antihistamines, anticancer, etc. Remus Pharmaceuticals' core business includes manufacturing approved finished formulations through loan licence and contract manufacturing, trading of Active Pharmaceutical Ingredients and Technical Consultancy on preparation of reports on pharmaceutical dossiers. It has a product portfolio of 429 products, 58 domestic distributors and 139 international distributors. Currently, the company is proposing an initial public offering of up to 388000 Equity Shares through its Fresh Issue.

Share Price: ₹2316.00 per share as on 10 Jan, 2025 04:03 PM
Market Capitalisation: ₹1,364.59Cr as of today
Listing date: 29 May, 2023
OrganisationRemus Pharmaceuticals Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Remus Pharmaceuticals Ltd

  • Remus Pharma Sees Spike in Trading Volumes - 01 Jul, 2024

    Remus Pharmaceuticals Ltd saw a spike in trading volumes on Friday, with rumors of AK-47 of small and micro caps investing in the stock. The stock has tripled over the last year due to improved operating performance and low floating stock.

  • Remus Pharmaceuticals ROCE Falls Despite Revenue Increase - 27 Jun, 2024

    Despite an increase in revenue and capital employed, Remus Pharmaceuticals' Return on Capital Employed (ROCE) has fallen from 39% to 25% in the last four years. The company's high current liabilities to total assets ratio of 58% introduces some risk, but reinvestment for growth could lead to long-term benefits for shareholders. The stock has returned 123% to shareholders in the last year.

Insights on Remus Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 3.00% to 3.16% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 70.66% to 70.84% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 25.61% to 25.22% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, REMUS stock has moved down by -15.0%

Remus Pharmaceuticals Ltd Financials

Value in ₹ crore
Details2021202220232024
Total Assets₹11.01Cr (-)₹15.86Cr (↑44.05%)₹34.66Cr (↑118.54%)₹98.06Cr (↑182.92%)
Total Liabilities₹7.87Cr (-)₹9.28Cr (↑17.92%)₹15.52Cr (↑67.24%)₹16.00Cr (↑3.09%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹1.30Cr (-)-₹0.12Cr (↓109.23%)₹5.04Cr (↓4,300.00%)₹5.31Cr (↑5.36%)₹2.43Cr (↓54.24%)

Remus Pharmaceuticals Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
70.84%
0.25
Foreign Institutions
3.16%
5.49
Mutual Funds
0%
0.00
Retail Investors
25.22%
-1.52
Others
0.77%
6.55

Remus Pharmaceuticals Ltd Key Indicators

Details2021202220232024
Return On Equity %41.0970.5866.133.24

Remus Pharmaceuticals Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Remus Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.

More on Technical Analysis

FAQs on Remus Pharmaceuticals Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Remus Pharmaceuticals Ltd shares.

Remus Pharmaceuticals Ltd (REMUS) share price today is ₹2316

Remus Pharmaceuticals Ltd is listed on NSE

Remus Pharmaceuticals Ltd is not listed on BSE

  • Today’s highest price of Remus Pharmaceuticals Ltd is ₹2348.
  • Today’s lowest price of Remus Pharmaceuticals Ltd is ₹2261.1.

Today’s traded volume of Remus Pharmaceuticals Ltd(REMUS) is 1,600.00.

Today’s market capitalisation of Remus Pharmaceuticals Ltd(REMUS) is ₹1364.59Cr.

Remus Pharmaceuticals Ltd(REMUSPrice
52 Week High
₹2834.75
52 Week Low
₹1200

Remus Pharmaceuticals Ltd(REMUS) share price is ₹2316. It is down -18.30% from its 52 Week High price of ₹2834.75

Remus Pharmaceuticals Ltd(REMUS) share price is ₹2316. It is up 93.00% from its 52 Week Low price of ₹1200

Remus Pharmaceuticals Ltd(REMUSReturns
1 Day Returns
6.65%
1 Month Returns
-7.79%
3 Month Returns
-15%
1 Year Returns
36.54%